USPTO 2015–2025 USPTO PatentsView US Corporation

CorMatrix Cardiovascular, Inc.

USPTO PatentsView assignee record - 85 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cormatrix ranks #4,190 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 9 technology areas.

#4,190
of 49,997 US assignees by volume
43rd percentile
by Innovation Score (33.0/100)
7.2
avg claims per patent
-80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4190 · US Corporation #4,190 · 85 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 85 grants
  • TOP-DECILE #4,190/49,997
  • PHOTO-FINISH Changzhou University
  • CPC-NARROW A61L · 9 areas
  • INNOV-THIN 33.0/100
  • CLAIMS-SPARSE 7.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -80% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Changzhou University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Cormatrix

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cormatrix's Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Cormatrix's grants concentrate

CorMatrix Cardiovascular, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 88.2% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2015 (21 grants) versus a trough of 4 in 2020. By volume, Cormatrix sits between Changzhou University and Given Imaging Ltd..

Cormatrix's three-year grant acceleration

CorMatrix Cardiovascular, Inc. shows 6 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at CorMatrix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CorMatrix holds 85 patents at rank #4,190, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CorMatrix

By rank, the assignees closest to #4,190 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in CorMatrix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CorMatrix, neither rank-band nor same-CPC leaders (those blocks stay above).

Cormatrix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0510152025 201520162017201820192020202120242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
CorMatrix Cardiovascular, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 21 24.7%
2016 16 18.8%
2017 19 22.4%
2018 7 8.2%
2019 7 8.2%
2020 4 4.7%
2021 4 4.7%
2024 6 7.1%
2025partial year 1 1.2%

Where it ranks

Overall rank by patents

#4,190

of 49,997 tracked assignees

Innovation Score

33.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

CorMatrix Cardiovascular, Inc.'s patent record in context - here's where to go next.

  • CorMatrix Cardiovascular, Inc.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 88.2% of its portfolio - see every assignee active in that class. Explore A61L
  • Ranked #4,190 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CorMatrix Cardiovascular, Inc. against Changzhou University, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.